KalVista Pharmaceuticals Announces Proposed Public Offering of Common Stock 3 years ago [#item_full_content] KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common StockDateFebruary 11, 2021In relation toSimilar postKalVista Pharmaceuticals Announces the Closing of its Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional SharesDateFebruary 16, 2021In relation toSimilar postANI Pharmaceuticals, Inc. Announces Proposed Public Offering of Common StockDateNovember 3, 2021In relation toSimilar post
